Exploring How Ear-Based Stimulation May Support Stress Recovery and Post-Viral Health
Ear-based stimulation has the potential to provide health systems with a scalable, low-risk tool to address some of today’s most pressing challenges: rising rates of anxiety and depression, persistent post-viral syndromes and the long-term burden of stress-related chronic conditions.
As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
Why ‘Time-to-Value’ Is the #1 Metric Healthcare AI Customers Care About
AI continues to dominate digital health funding, but investors and health systems are demanding proof that these tools actually save money — and quickly. AI startups without clear, measurable ROI are finding it harder to stand out, explained Vig Chandramouli, partner at Oak HC/FT.
UHC Taps Aeroflow Health for Virtual Nutrition Services
UnitedHealthcare has partnered with Aeroflow Health to provide virtual, dietitian-led nutrition services for members managing chronic conditions.
UCB Drug Becomes First FDA-Approved Treatment for Ultra-Rare and Fatal Mitochondrial Disease
The FDA has approved UCB’s Kygevvi for treating children and adults with thymidine kinase 2 deficiency, an inherited mitochondrial disorder. It’s the drugmaker’s first ultra-rare disease product.